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Immediate Versus Delayed Insertion of the Levonorgestrel
Intrauterine Device in Postpartum Adolescents:
A Randomized Pilot Study
Reni Soon MD, MPH; Katie McGuire MD;, Jennifer Salcedo MD, MPH, MPP;
and Bliss Kaneshiro MD, MPH
Abstract

This pilot study assessed the feasibility of conducting a larger randomized
controlled trial comparing the proportion of adolescents using a levonorgestrel
intrauterine device (LNG IUD) at six months postpartum when it is inserted
immediately after vaginal delivery (within 10 minutes after placental expulsion)
compared to insertion four to six weeks postpartum. Pregnant adolescents
(14 to 19 years) who desired a LNG IUD for postpartum contraception were
randomized to insertion of the LNG IUD either within 10 minutes of delivery of
the placenta or at 4-6 weeks postpartum. Study follow-up visits were conducted
at 4-6 weeks postpartum, 10 weeks postpartum, and 6 months postpartum.
From November 2013 to June 2015, eleven adolescents were randomized six participants to the immediate postpartum LNG IUD insertion group, and
five to the delayed insertion group. All six women in the immediate insertion
group had successful immediate postpartum insertion; two of five women in
the delayed insertion group had an IUD inserted. At six months postpartum,
four of six women in the immediate insertion group had a LNG IUD in place;
of the five women in the delayed group, three did not have a LNG IUD in place
and two were pregnant. The study was discontinued after 19 months because
of suboptimal enrollment. Though insertion of a LNG IUD immediately after
delivery is an appropriate option for some adolescents, a larger prospective
study comparing immediate to delayed LNG IUD insertion is unlikely to be
feasible at our institution.
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Introduction
Immediate postpartum insertion of long acting reversible contraception (LARC) is increasingly recognized as a useful approach to reduce unintended pregnancies.1 Among adolescents,
75% of pregnancies are unintended2 and one in five adolescent
mothers becomes pregnant again within 12 months of delivery.3
In Hawai‘i, 17% of all births among women age 15 to 19 years
are repeat births.4 To avoid increasing the socioeconomic hardship,5-8 and pregnancy complications9 associated with repeat
adolescent births, access to immediate postpartum contraception
is particularly important in this population.

LARC methods, including the copper and levonorgestrel
(LNG) intrauterine devices (IUDs) and the contraceptive implant, are described as first-line contraceptives for adolescents
and adults by the American College of Obstetricians and Gynecologists.10 LARC methods require little action on the part
of the patient after insertion, resulting in typical-use effectiveness of 99.8% in the first year of use.11,12 Women using the oral
contraceptive pill, patch, and ring are 22 times more likely to
become pregnant in the first year of use compared with women
using a LARC method.13
Programs most successful at reducing rapid repeat adolescent pregnancy have generally included promotion of LARC
methods.3,14,15 Immediate postpartum IUD insertion, defined as
insertion of an IUD within ten minutes of placental delivery,
has been studied in adult women. Insertion in this setting is
convenient for the patient and the provider, bypasses many of the
barriers that are present when women wait the standard four to
six weeks following delivery for IUD insertion, and ensures that
the woman is not pregnant at the time of insertion. An increasing number of studies have investigated immediate postpartum
insertion of the LNG IUD,16-20 but most lack randomization
and fail to provide adequate information on adolescents. Not
only do adolescents disproportionately experience unintended
pregnancy, but they also may be differently affected by factors like expulsion rates and the desire for reinsertion of the
device compared to adults. Furthermore, adolescent mothers
typically face more barriers to care following discharge from
the hospital.21
The aim of this pilot study was to determine the feasibility
of conducting a large randomized controlled trial comparing
the proportion of adolescents using a LNG IUD at 6 months
postpartum when it is placed within 10 minutes of delivery
of the placenta following vaginal delivery (immediate insertion) versus four to six weeks postpartum (delayed insertion).
We also aimed to identify methodological challenges and the
percent attrition in both study groups. Additional outcomes
included patient satisfaction, expulsion, bleeding patterns, and
breastfeeding rates.
Materials and Methods
This prospective, randomized pilot study was conducted at
Kapi‘olani Medical Center for Women and Children in Honolulu,
Hawai‘i, which is the primary training site for the University of
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Hawai‘i (UH) John A. Burns School of Medicine Department
of Obstetrics and Gynecology (OB/GYN) residency program.
We enrolled pregnant adolescents (14 to 19 years old) who
planned to use a LNG-IUD after delivery and randomized
participants to immediate postpartum or delayed insertion of
the LNG-IUD. We excluded women with an allergy to the
LNG-IUD; chlamydia or gonorrhea during pregnancy without
a negative test-of-cure result; an anomaly distorting the uterine
cavity; current cervical cancer; a desire for a repeat pregnancy
within one year; plans to move from Oahu less than six months
after delivery; a planned cesarean delivery; or a delivery at less
than 34 weeks gestation. This study received approval from the
Western Institutional Review Board.
Potential participants were identified either at their presentation to the labor and delivery suite or at their prenatal visits at
the UH resident or faculty practice clinics. Potential participants
were approached about the study at 24 weeks gestation or greater,
and were assured that their care would not be affected whether
they chose to participate in the study or not. If an antepartum
patient expressed interest in enrolling, a notation was made
in her chart. Patients were then screened for eligibility and
enrolled in the study at the time of presentation to the labor
and delivery suite. After consent was obtained, participants
completed a demographic and medical information questionnaire. Study personnel placed one of the sequentially numbered,
opaque sealed envelopes with the participant’s allocation assignment in the delivery room. A statistician not involved with
the conduct of the study used a true random number generator
to develop the 1:1 randomization scheme using block sizes of
six. Subsequent exclusion criteria included: chorioamnionitis,
postpartum hemorrhage, unanticipated cesarean delivery, and
delivery at a time when a study investigator was unavailable.
To limit post-randomization exclusions, the envelope with the
participant’s allocation assignment was opened after delivery.
If exclusion criteria were met after consent, the unopened
envelope with the study allocation assignment was returned to
the stack of envelopes to maintain sequential numbering.
Patients randomized to immediate insertion had their procedure performed within ten minutes of delivery of the placenta by
study investigators or UH OB/GYN residents under the direct
supervision of study investigators. Insertions were performed
using a technique similar to that described by O’Hanley, et
al,22 and Hayes, et al.16 After placental expulsion and uterine
massage, the IUD was removed from the inserter and placed by
hand at the uterine fundus. The other hand palpated the fundus
abdominally to ensure that the hand inserting the IUD was at
the fundus. If placement by hand was not possible due to patient
discomfort, ring forceps were used to insert the IUD using a
technique described by Speroff and Mishell23 and employed
in the study by Dahlke, et al.18 Strings were trimmed three
centimeters from the external os. While ultrasound was not a
routine part of the study protocol, use was left to the discretion
of the treating physicians. Participants randomized to delayed
insertion had the LNG IUD placed four to six weeks following delivery using the standard technique by their obstetrician
(residents with faculty supervision or faculty).

Study visits were scheduled at four to six weeks, ten weeks,
and six months postpartum. Participants were given a $5 online
gift card at each study visit as compensation for their time.
A study coordinator scheduled the four to six week follow up
visit prior to hospital discharge. At each study visit, a pelvic
exam was performed and if the IUD strings were not visible,
an ultrasound was performed to confirm intrauterine position.
If the IUD was visible in the cervix, it was considered an
expulsion and was removed. Any patient who experienced an
expulsion during the six-month study period was counseled
about all contraceptive options and was given the option of
insertion of another LNG IUD at no cost. Participants were
also asked about bleeding, cramping, fever, pain, sexual activity, and breastfeeding. Participants rated their satisfaction with
the LNG IUD on a 10-cm Visual Analog Scale, anchored at 0
being very unsatisfied and 10 being very satisfied. Participants
who wished to have the LNG IUD removed could return at any
time during the 6-month postpartum study period to do so at
no cost.
Three phone calls were made to participants who did not
return for their follow up visits. If a participant declined an
in-person visit, phone follow-up was done and participants
were asked all the questions that would have been asked in
an in-person visit, as well as additional questions to assess the
likelihood of IUD expulsion. The patient’s medical record was
reviewed to determine if she sought care related to the IUD or
had a postpartum complication.
The sample size of this pilot study was estimated to determine feasibility of a larger study. We used principles outlined
by Hertzog24 to estimate that a sample size of 30 participants,
15 in each group, would be needed to adequately describe recruitment, post-enrollment exclusion, and attrition to determine
the feasibility of a larger study. With this sample size and an
observed 15% attrition rate we could be 68% confident that our
estimates would be accurate within 8 percentage points.
The study was discontinued prior to meeting our sample size
goal due to suboptimal enrollment. We had planned to compare
the proportion of participants who continued to use the LNG IUD
at six months with Chi-square or Fisher’s exact tests. Patients
who experienced an expulsion but had an IUD reinserted would
have been classified as using an IUD, and we were planning to
analyze using intention-to-treat principles. However, because
the study had to be discontinued, the participants and their
follow-up are described.
Results
From November 2013 to June 2015, 18 women verbally agreed
to participate. Seven women were excluded prior to randomization – three women had a cesarean section, one developed
chorioamnionitis, one delivered at less than 34 weeks gestation,
one declined insertion of an IUD, and for one participant the
reason for exclusion was not recorded. Of the eleven women
remaining, six were randomized to immediate insertion and
five to delayed insertion.
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Patient demographic factors are described in Table 1. The
mean age of participants was 18.4 years. Six participants had
been previously pregnant, and three had experienced a prior
delivery. Five of the participants had never used a form of
contraception; four had used condoms; and four had used a
short-term hormonal contraceptive.
All of the participants and their course through the study
are detailed in Table 2 and Figure 1. Of the six participants
randomized to immediate IUD insertion, all six had successful insertion of their IUDs immediately postpartum (100%
insertion), and four (67%) had the IUD in place at six months
postpartum. One participant in the immediate insertion group
had an IUD expulsion prior to her 4-6 week follow-up visit and
did not desire IUD replacement. She was unable to be reached
for the 10-week follow-up and 6-month follow-up visits. The
other participant randomized to immediate insertion requested
removal of her IUD at her 10-week visit because of some discomfort she attributed to the IUD and requested a contraceptive
injection. She could not be reached for her 6-month follow-up.
Of the five participants randomized to delayed IUD insertion
at follow-up, only two had an IUD inserted (40% insertion). At
six months, one of the two had had her IUD removed a month
after insertion and was pregnant; the other was unable to be
reached. Of the three participants randomized to delayed insertion who never had an IUD inserted, one of them presented to the
labor and delivery suite eleven months postpartum with a term
pregnancy, and two declined IUD insertion at their follow-up
visits. At six months postpartum, three of the five participants
randomized to delayed IUD insertion did not have IUDs in
place and two of the three were pregnant.
Some of the participants followed up at outside facilities
instead of the resident clinic where study visits were conducted.
Of the 18 follow-up visits among the immediate insertion
participants, 14 were completed (78%); of the 15 follow-up
visits among delayed insertion participants, six (40%) were
Table 1. Participant Characteristics
Immediate Postpartum
Group
(n=6)

Delayed
Group
(n=5)

18.33 ± 1.03

18.40 ± 0.89

Non-Hispanic white

1 (17%)

1 (20%)

Non-Hispanic black

1 (17%)

0 (0%)

Asian

1 (17%)

1 (20%)

Native Hawaiian/Pacific Islander

4 (67%)

4 (80%)

3 (50%)

3 (60%)

Characteristic
Mean age (years ± SD)
Race*

Previously used contraception**
Previously used IUD or implant

0 (0%)

0 (0%)

Previously pregnant

1 (17%)

5 (100%)

Previous delivery
0 (0%)
3 (60%)
*Participants could identify more than one race
**Contraceptive methods asked about: IUD, implant, injection, oral contraceptive,
patch, ring, condoms

completed, but two were completed over the phone and two were
completed at an outside facility. Because of this, we have data
on contraceptive method at the time of the visit but do not have
data for most participants on bleeding patterns, breastfeeding,
sexual activity or contraceptive method satisfaction. Therefore
we are unable to comment on any differences in these outcomes
between groups. Of the six participants who had follow-up
visits in the resident clinic, five were in the immediate insertion group. Four of these five expressed a preference for IUD
insertion immediately postpartum over delayed insertion and
rated their experience as “very satisfied.” One participant who
had an immediate insertion and had an IUD expulsion prior to
her 4-6 week visit stated she would prefer delayed IUD insertion over immediate. One participant in the delayed insertion
group, and the only one from that group who followed-up in
the resident clinic and therefore the only one who was asked
the question, stated she did not have a preference for immediate
or delayed IUD insertion.
Discussion
Although we found that a larger randomized controlled trial
comparing immediate to delayed postpartum LNG IUD insertion
among adolescents is not feasible at our institution, we describe
a small cohort of adolescent women in Honolulu who appear
to have benefitted from immediate postpartum IUD insertion.
Of the women randomized to immediate insertion, four of the
six had an IUD in place at six months postpartum. Four of the
six women expressed a preference of immediate insertion over
delayed insertion and were “very satisfied” with their experience. Of the five women randomized to delayed insertion, three
of them did not have an IUD in place at six months postpartum
and two of the women had again become pregnant. Our findings are consistent with other studies in adult women showing
that many women who have immediate postpartum insertions
of a LNG IUD are using an IUD at six months postpartum.18-20
Most of these studies also report high patient satisfaction with
immediate postpartum placement.
Suboptimal enrollment and difficulty in following up with
participants precluded conduct of any of the planned analyses.
While LARC use among adolescents is increasing, overall rates
of use are still low and most of the increase seen has been in the
use of the contraceptive implant. In an analysis of contraceptive method use among sexually active women age 15-19 years
from 2011-2015, 2.8% had used an IUD (increase from 2.5%
in 2006-2010) and 3.0% had used an implant (increased from
0.6% in 2006-2010).25 Our suboptimal enrollment reflects this
overall low rate of IUD use among adolescents. In addition,
follow-up with our adolescent participants was challenging.
Only 78% of potential follow-up visits were conducted in the
immediate insertion group compared to 40% in the delayed
insertion group. While it is not surprising that the participants
who received the intervention were more likely to follow-up,
this leads to ascertainment bias in addition to poor overall
obtainment of outcome data.
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Table 2. Study Participants and Follow-up
Age

Pregnancy
history

Previous birth
control used

4-6 wk f/u –
IUD in place?

10 wk f/u – IUD
in place?

6 mo f/u – IUD
in place?

IUD in place at
4-6 weeks

IUD in place at
6 months

Preference
for timing of
IUD placement
(asked at all f/u
visits)

Immediate insertion group
19

G1P0

None

No – expulsed.
Did not want
replacement

Unable to
contact

Unable to
contact

No

Unknown

Delayed

19

G1P0

OCPs

Yes

Yes

Yes

Yes

Yes

Immediate for
all 3 visits

19

G2P0

None

Yes

Yes

Yes

Yes

Yes

Immediate for
all 3 visits

17

G1P0

None

Yes

Unable to
contact

Yes (visit was
at 9 months
postpartum)

Yes

Yes

Visit was at outside facility and
was not asked

19

G1P0

Condoms

Yes

Yes

Yes

Yes

Yes

Immediate for
all 3 visits

17

G1P0

Condoms,
DMPA

Yes

Requested IUD
removal; got
DMPA

Unable to
contact

Yes

Unknown

Immediate for 2
visits

Condoms,
OCPs

IUD inserted

Unable to
contact

Unable to
contact

Yes

Unknown

“Do not care”

IUD inserted at
outside facility

Unable to
contact

Presented to
outside facility
for pregnancy
test (positive).
Stated had
IUD removed
1 month after it
was placed

Yes

No

Was not asked

Unable to
contact

*Stated she
received DMPA
injection postpartum and was
not sure what
method she
wanted to use

*Stated she did
not have an
IUD and was
not sure what
method she
wanted to use

No

No

Was not asked

No

Was not asked

Unknown

Was not asked

Delayed insertion group
18

17

G2P1

G2P1

Condoms

19

G2P0

None

19

G3P2

DMPA

No f/u, but 11 mos later admitted to hospital in labor with another full-term
pregnancy

None

No. Stated she
wanted the
contraceptive
implant but
never returned

19

G2P0

Unable to
contact

Unable to
contact

No

*Follow-up by phone
Abbreviations: G=gravidity (number of pregnancies), P=parity (number of deliveries), DMPA=Depot medroxyprogesterone acetate (contraceptive injection),
OCPs=oral contraceptive pills
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Figure 1. Study Participants and Follow-up
Despite the challenges of this study, the randomized controlled
study design is critical to examining whether adolescents benefit
from access to immediate postpartum IUD. While one cohort
study of 82 adolescent (13-22 year-old) women who chose
immediate postpartum IUD insertion found that 71% were still
using an IUD at six months postpartum,20 cohort studies are
subject to selection bias. Unrecognized differences between
patients who choose immediate insertion versus women who
choose standard delayed insertion can affect outcomes. In addition, a healthcare provider may be more likely to recommend
immediate postpartum insertion to a patient thought to be at
higher risk of short interval pregnancy or poor follow-up. Ways
to mitigate challenges in a study such as this may include use
of a closed healthcare system, higher compensation for study
visits, and alternative methods of follow-up such as text messaging or online surveys.
At our institution in Honolulu, adolescents are offered immediate postpartum IUD insertion because follow-up rates for
postpartum visits are low in this group. While we found that a
larger randomized controlled trial to examine this question is not
feasible at our institution, we were able to describe a small group
of local adolescents who benefitted from immediate postpartum
IUD placement. In contrast, of the five adolescents who were
randomized to delayed IUD insertion, two were pregnant again
by six months after their delivery. Immediate postpartum IUD
insertion may be an effective way to increase use of a highly

effective contraceptive method in a group of young women at
high risk for unintended pregnancy.
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